First-generation antipsychotics have a high rate of extrapyramidal side effects, including rigidity, bradykinesia, dystonias, tremor, and akathisia. Tardive dyskinesia —involuntary movements of the face and extremities — is another adverse effect that can occur with first-generation antipsychotics. Patients find these muscle symptoms uncomfortable, and this often leads to nonadherence with medication.
Second-generation (novel or atypical) antipsychotics, with the exception of aripiprazole, are dopamine D2 antagonists but are associated with lower rates of extrapyramidal adverse effects and tardive dyskinesia than the first-generation antipsychotics. However, they have higher rates of metabolic adverse effects, including abnormalities in glucose and lipid control, and weight gain.
Learn more about schizophrenia medication.
Editor's Recommendations
Medscape © 2020 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Stephen Soreff. Fast Five Quiz: Schizophrenia Management in Adults - Medscape - Aug 11, 2020.
Comments